Region: United States of America

USPTO’s subject matter eligibility pilot may save IP owners money, but still leaves a lot to be desired

Patent applicants may save legal costs by deferring responses on eligibility rejections, write Panitch Schwarze Belisario & Nadel partners Erin Dunston and Stephen Murray, but the USPTO programme won’t realise efficiency for examiners or fix the US patent eligibility law mess

25 January 2022

Biden administration is right to pursue a ‘China Initiative’ reset

Even some of the programme’s architects seem to agree that it has strayed from initial focus on trade secrets and intellectual property

22 January 2022

Ex-Samsung IP head’s involvement in NPE suit raises eyebrows

Court filings show Seungho Ahn, who led the Korean tech giant’s IP function until 2019, is closely involved in a patent assertion against his former employer

21 January 2022

We should fight it out with Ericsson in Texas, Apple tells the ITC

Case filed yesterday by the iPhone giant makes clear that it wants its patent licensing dispute with the Swedish company to centre on the US court system

20 January 2022

Discretionary denials impact US life sciences IP strategies, but not as much as might be thought

SCOTUS refuses to consider NHK-Fintiv legal challenges, with significant implications for PTAB actions

20 January 2022

Ericsson sues Apple for patent infringement as cross-licence deal expires

Swedish telco asserts patents against the iPhone maker in the Western District of Texas and at least one jurisdiction outside the US

18 January 2022

The Western District of Texas is a problem, but not for the reasons you think

Saturday Opinion: the popularity of Judge Alan Albright’s court as a venue for plaintiffs in patent cases comes down to so many of them not feeling they have a fair chance elsewhere

15 January 2022

Without injunctions, the US patent system is rigged in favour of deep pocket defendants

Sonos’s recent win over Google at the ITC demonstrates the importance of innovators having the ability to exclude infringers from practising on their inventions

14 January 2022

Skinny label concerns persist for generics, despite good news from Delaware

A district court judge has thrown out an induced infringement allegation against Hikma Pharmaceutical, but big questions remain over drug label carve-outs

14 January 2022

IBM comes very close to losing its US patent leadership crown

Kyndryl spin-out saw Samsung get within 24 grants of taking the top slot from Big Blue in 2021

13 January 2022

Get unlimited access to all IAM content